Despite immunization appearing to be the most appropriate strategy for long‐term control of the vector‐borne leishmaniases, no sustainable vaccine is currently available against any form of leishmaniasis. We therefore evaluated, in the context of vaccine antigen candidates, antigen‐specific immune response at various stages of cutaneous leishmaniasis (CL).

中文翻译：

---

皮肤利什曼病患者抗原特异性免疫反应的演变

尽管免疫似乎是长期控制媒介传播的利什曼病最合适的策略，但目前还没有针对任何形式的利什曼病的可持续疫苗。因此，我们在候选疫苗抗原的背景下评估了皮肤利什曼病 (CL) 各个阶段的抗原特异性免疫反应。